We are routinely coming across pharma companies (small & large) who just don’t keep up with or monitor changes in packaging legislation that will have a major impact on their businesses. A good example is the impending Braille legislation which is now MANDATORY for ALL pharma packs sold in Europe and has to be in place within the next 7 MONTHS. As a consequence of non-compliance, an estimated 20% of pharma companies could have their products delisted. So why do companies ignore it?